MoneyWorks4Me

Cipla informs about acquisition

06 Jan 2024 Evaluate
Cipla has informed that Cipla (EU), wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1442.50 4.85 (0.34%)
21-Aug-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1919.50
Dr. Reddys Labs. 1175.55
Cipla 1442.50
Lupin 2203.50
Zydus Lifesciences 1106.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: